Ganetespib and Ziv-Aflibercept in Refractory Gastrointestinal Carcinomas, Non-Squamous Non-Small Cell Lung Carcinomas, Urothelial Carcinomas, and Sarcomas
Condition(s):NeoplasmsLast Updated:March 29, 2018Terminated
Hide Studies Not Open or Pending
Condition(s):NeoplasmsLast Updated:March 29, 2018Terminated
Condition(s):Colorectal CancerLast Updated:October 5, 2021Unknown status
Condition(s):Colorectal Cancer MetastaticLast Updated:March 17, 2015Unknown status
Condition(s):Colorectal Cancer Stage IVLast Updated:February 23, 2022Unknown status
Condition(s):Colorectal Cancer; Oligometastatic DiseaseLast Updated:October 17, 2023Recruiting
Condition(s):Advanced Solid Tumors; Kirsten Rat Sarcoma (KRAS) pG12C MutationLast Updated:February 29, 2024Recruiting
Condition(s):Colorectal Cancer; Resectable Colorectal CarcinomaLast Updated:September 21, 2023Recruiting
Condition(s):Colonic Cancer; Unresectable Metastasis Originating in Colonic CancerLast Updated:March 16, 2021Terminated
Condition(s):Colorectal Cancer; Non-Small Cell Lung CancerLast Updated:April 6, 2023Terminated
Condition(s):Colorectal CancerLast Updated:October 26, 2017Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.